SIAH2 and cholangiocarcinoma: Similar to NSCLC, in cholangiocarcinoma (CCA), METTL14 binds Siah2 mRNA in the 3′-UTR region and triggers m6A modification, promoting its degradation in a YTHDF2-dependent manner.